Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Oncotarget
|
April 15, 2016
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations
Harshabad Singh, Yang Liu, Xiuli Xiao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 8, 2019
Performance of <sup>18</sup>F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer
Barbara J Amorim, Vinay Prabhu, Sara S Marco, et al.
Journal of Neurosurgery. Spine
|
June 25, 2021
The effectiveness of systemic therapies after surgery for metastatic renal cell carcinoma to the spine: a propensity analysis controlling for sarcopenia, frailty, and nutrition
Elie Massaad, Philip J Saylor, Muhamed Hadzipasic, et al.
Abdominal Radiology (New York)
|
September 20, 2025
Prognostic value of MRI-derived features for biochemical recurrence after curative radiotherapy in prostate cancer
Alexander Herold, Maximilian Pohl, Stephan M Korn, et al.
The Oncologist
|
February 4, 2012
Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer
Philip J Saylor, Kevin R Kozak, Matthew R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2020
Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline
Philip J Saylor, R Bryan Rumble, Scott Tagawa, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
March 18, 2024
Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer
Timothy W Churchill, Matthew R Smith, M Dror Michaelson, et al.
Molecular Cancer Research : MCR
|
March 19, 2025
Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis
Shenglin Mei, Hanyu Zhang, Taghreed Hirz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2016
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
Philip J Saylor, Richard J Lee, Kshitij S Arora, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Oncotarget
|
April 15, 2016
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations
Harshabad Singh, Yang Liu, Xiuli Xiao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 8, 2019
Performance of <sup>18</sup>F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer
Barbara J Amorim, Vinay Prabhu, Sara S Marco, et al.
Journal of Neurosurgery. Spine
|
June 25, 2021
The effectiveness of systemic therapies after surgery for metastatic renal cell carcinoma to the spine: a propensity analysis controlling for sarcopenia, frailty, and nutrition
Elie Massaad, Philip J Saylor, Muhamed Hadzipasic, et al.
Abdominal Radiology (New York)
|
September 20, 2025
Prognostic value of MRI-derived features for biochemical recurrence after curative radiotherapy in prostate cancer
Alexander Herold, Maximilian Pohl, Stephan M Korn, et al.
The Oncologist
|
February 4, 2012
Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer
Philip J Saylor, Kevin R Kozak, Matthew R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2020
Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline
Philip J Saylor, R Bryan Rumble, Scott Tagawa, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
March 18, 2024
Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer
Timothy W Churchill, Matthew R Smith, M Dror Michaelson, et al.
Molecular Cancer Research : MCR
|
March 19, 2025
Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis
Shenglin Mei, Hanyu Zhang, Taghreed Hirz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2016
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
Philip J Saylor, Richard J Lee, Kshitij S Arora, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Page
of 9